243 related articles for article (PubMed ID: 10952495)
41. Safety and efficacy of total thyroidectomy for differentiated thyroid carcinoma: a 20-year review.
Ley PB; Roberts JW; Symmonds RE; Hendricks JC; Snyder SK; Frazee RC; Smith RW; McKenney JF; Brindley GV
Am Surg; 1993 Feb; 59(2):110-4. PubMed ID: 8476139
[TBL] [Abstract][Full Text] [Related]
42. Association of tumor size and focality with recurrence/persistence in papillary thyroid cancer patients treated with total thyroidectomy along with radioactive-iodine ablation and TSH suppression.
Khan M; Syed AA; Khan AI; Hussain SR; Urooj N
Updates Surg; 2018 Mar; 70(1):121-127. PubMed ID: 28550398
[TBL] [Abstract][Full Text] [Related]
43. Role of Postoperative Stimulated Thyroglobulin as Prognostic Factor for Differentiated Thyroid Cancer in Children and Adolescents.
Zanella A; Scheffel RS; Pasa MW; Dora JM; Maia AL
Thyroid; 2017 Jun; 27(6):787-792. PubMed ID: 28292215
[TBL] [Abstract][Full Text] [Related]
44. Prevalence, clinical significance and prognostic value of anti-thyroglobulin antibodies in the follow-up of patients with differentiated thyroid carcinoma: a retrospective study.
Pedrazzini L; Baroli A; Lomuscio G; Marzoli L
Minerva Endocrinol; 2009 Sep; 34(3):195-203. PubMed ID: 19859043
[TBL] [Abstract][Full Text] [Related]
45. Long-term outcomes of distant metastasis from differentiated thyroid carcinoma.
Huang IC; Chou FF; Liu RT; Tung SC; Chen JF; Kuo MC; Hsieh CJ; Wang PW
Clin Endocrinol (Oxf); 2012 Mar; 76(3):439-47. PubMed ID: 21950769
[TBL] [Abstract][Full Text] [Related]
46. Papillary thyroid carcinoma: 35-year outcome and prognostic factors in 1858 patients.
Pelizzo MR; Boschin IM; Toniato A; Piotto A; Pagetta C; Gross MD; Al-Nahhas A; Rubello D
Clin Nucl Med; 2007 Jun; 32(6):440-4. PubMed ID: 17515749
[TBL] [Abstract][Full Text] [Related]
47. Pure versus follicular variant of papillary thyroid carcinoma: clinical features, prognostic factors, treatment, and survival.
Zidan J; Karen D; Stein M; Rosenblatt E; Basher W; Kuten A
Cancer; 2003 Mar; 97(5):1181-5. PubMed ID: 12599223
[TBL] [Abstract][Full Text] [Related]
48. Higher preablative serum thyroid-stimulating hormone level predicts radioiodine ablation effectiveness in patients with differentiated thyroid carcinoma.
Lawal IO; Nyakale NE; Harry LM; Lengana T; Mokgoro NP; Vorster M; Sathekge MM
Nucl Med Commun; 2017 Mar; 38(3):222-227. PubMed ID: 28002173
[TBL] [Abstract][Full Text] [Related]
49. Association between residual thyroid carcinoma and diffuse hepatic uptake of 131I following radioiodine ablation in postoperative total thyroidectomy patients.
Tatar FA; Morita E; Ituarte PH; Cavalieri RR; Duh QY; Price DC; Siperstein AE; Clark OH
World J Surg; 2001 Jun; 25(6):718-22. PubMed ID: 11376405
[TBL] [Abstract][Full Text] [Related]
50. [Differentiated thyroid carcinoma--essential for the practitioner].
Binz K; Haldemann A; Meier CA
Ther Umsch; 2011 Jun; 68(6):291-5. PubMed ID: 21656486
[TBL] [Abstract][Full Text] [Related]
51. Selective treatment of differentiated thyroid carcinoma.
Gemsenjäger E; Heitz PU; Martina B
World J Surg; 1997 Jun; 21(5):546-51; discussion 551-2. PubMed ID: 9204746
[TBL] [Abstract][Full Text] [Related]
52. Radioactive iodine (RAI) therapy for distantly metastatic differentiated thyroid cancer (DTC) in juvenile versus adult patients.
Kammori M; Fukumori T; Sugishita Y; Hoshi M; Shimizu K; Yamada T
Endocr J; 2015; 62(12):1067-75. PubMed ID: 26424174
[TBL] [Abstract][Full Text] [Related]
53. [Papillary and follicular cancers of the thyroid].
Schlumberger M; Baudin E; Travagli JP
Presse Med; 1998 Oct; 27(29):1479-81. PubMed ID: 9798467
[TBL] [Abstract][Full Text] [Related]
54. Rate of elimination of radioiodine-avid lymph node metastases of differentiated thyroid carcinoma by postsurgical radioiodine ablation. A bicentric study.
Ilhan H; Mustafa M; Bartenstein P; Kuwert T; Schmidt D
Nuklearmedizin; 2016 Dec; 55(6):221-227. PubMed ID: 27588323
[TBL] [Abstract][Full Text] [Related]
55. Outcomes and prognostic factors of 251 patients with minimally invasive follicular thyroid carcinoma.
Sugino K; Kameyama K; Ito K; Nagahama M; Kitagawa W; Shibuya H; Ohkuwa K; Yano Y; Uruno T; Akaishi J; Suzuki A; Masaki C; Ito K
Thyroid; 2012 Aug; 22(8):798-804. PubMed ID: 22853727
[TBL] [Abstract][Full Text] [Related]
56. Thyroid carcinoma in childhood: management and follow up of 11 cases.
Jocham A; Joppich I; Hecker W; Knorr D; Schwarz HP
Eur J Pediatr; 1994 Jan; 153(1):17-22. PubMed ID: 8313918
[TBL] [Abstract][Full Text] [Related]
57. Radioiodine ablation of thyroid remnants in patients with differentiated thyroid carcinoma (DTC) following administration of rhTSH - a comparison with L-thyroxine withdrawal.
Bałdys-Waligórska A; Gołkowski F; Krzentowska-Korek A; Hubalewska-Dydejczyk A
Endokrynol Pol; 2010; 61(5):474-9. PubMed ID: 21049461
[TBL] [Abstract][Full Text] [Related]
58. Pediatric Differentiated Thyroid Carcinoma in The Netherlands: A Nationwide Follow-Up Study.
Klein Hesselink MS; Nies M; Bocca G; Brouwers AH; Burgerhof JG; van Dam EW; Havekes B; van den Heuvel-Eibrink MM; Corssmit EP; Kremer LC; Netea-Maier RT; van der Pal HJ; Peeters RP; Schmid KW; Smit JW; Williams GR; Plukker JT; Ronckers CM; van Santen HM; Tissing WJ; Links TP
J Clin Endocrinol Metab; 2016 May; 101(5):2031-9. PubMed ID: 26963949
[TBL] [Abstract][Full Text] [Related]
59. [Thyroid differenciated carcinoma in children. Study from Normandy].
Blanchard D; Choussy O; Rame J; Bequigon A; Dehesdin D; De Raucourt D; Bardet S; Babin E
Rev Laryngol Otol Rhinol (Bord); 2011; 132(4-5):197-201. PubMed ID: 22908540
[TBL] [Abstract][Full Text] [Related]
60. Long-term follow-up of patients with bone metastases from differentiated thyroid carcinoma -- surgery or conventional therapy?
Zettinig G; Fueger BJ; Passler C; Kaserer K; Pirich C; Dudczak R; Niederle B
Clin Endocrinol (Oxf); 2002 Mar; 56(3):377-82. PubMed ID: 11940050
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
